Lake Bluff, IL, United States of America

Tongmei Li

USPTO Granted Patents = 26 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 17)

Average Co-Inventor Count = 9.5

ph-index = 6

Forward Citations = 250(Granted Patents)

Location History:

Waukegan, IL (US) (2004 - 2008)
Lake Bluff, IL (US) (2010 - 2018)

Company Filing History:

Abbott Laboratories Corporation

patents

Years Active: 2004-2018

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10053474 - Anti-viral compounds (2018-08-21),

2. 9676797 - Anti-viral compounds (2017-06-13),

3. 9193713 - Compounds as cannabinoid receptor ligands (2015-11-24),

4. 9006275 - Compounds as cannabinoid receptor ligands and uses thereof (2015-04-14),

5. 8895592 - Compounds as cannabinoid receptor ligands (2014-11-25),

6. 8859596 - Compounds as cannabinoid receptor ligands (2014-10-14),

7. 8859549 - Potassium channel modulators (2014-10-14),

8. 8846730 - Compounds as cannabinoid receptor ligands (2014-09-30),

9. 8841334 - Compounds as cannabinoid receptor ligands and uses thereof (2014-09-23),

10. 8835475 - Compounds as cannabinoid receptor ligands (2014-09-16),

11. 8629143 - Potassium channel modulators (2014-01-14),

12. 8546583 - Compounds as cannabinoid receptor ligands and uses thereof (2013-10-01),

13. 8546374 - Amino-tetrazoles analogues and methods of use (2013-10-01),

14. 8501794 - Compounds as cannabinoid receptor ligands (2013-08-06),

15. 8492371 - Compounds as cannabinoid receptor ligands (2013-07-23),

Title: The Innovative Contributions of Tongmei Li

Introduction

Tongmei Li, based in Lake Bluff, Illinois, stands out as a prominent inventor in the field of anti-viral compounds. With an impressive portfolio of 26 patents, his work primarily focuses on combating the Hepatitis C virus (HCV). Li’s dedication to innovation is reflected in his recent advancements in developing effective compounds for treating this challenging viral infection.

Latest Patents

Among Tongmei Li's latest patents are groundbreaking anti-viral compounds specifically designed to inhibit the activity of HCV polymerase. These inventions not only include the compounds themselves but also elaborate on the processes for their synthesis and the various compositions that incorporate these compounds. Furthermore, they outline methods for utilizing these compounds in the treatment of HCV infection, showcasing his commitment to addressing a critical health issue.

Career Highlights

Throughout his career, Tongmei Li has made significant contributions while working with notable companies in the pharmaceutical sector, such as AbbVie Inc. and Abbott Laboratories Corporation. These organizations have provided him with the platform to develop and refine his innovative ideas, leading to numerous patents that reflect his expertise and dedication.

Collaborations

In his professional journey, Tongmei Li has had the opportunity to collaborate with exceptional colleagues, including Arturo Perez-Medrano and Sridhar Peddi. These partnerships have not only enriched his research but have also fostered an environment of collaboration leading to successful innovations in the field of virology.

Conclusion

Tongmei Li’s contributions to the development of anti-viral compounds are commendable and highlight his importance as an inventor in the pharmaceutical landscape. With 26 patents to his name, his work continues to inspire and pave the way for advancements in treating Hepatitis C, ultimately contributing to better health outcomes for patients around the globe. His dedication to innovation and collaboration exemplifies the essence of scientific progress in the modern era.

This text is generated by artificial intelligence and may not be accurate.